CALGARY, ALBERTA - March 4, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek ...
Calgary, Alberta, Canada – April 23, 2025 –TheNewswire -Voyageur Pharmaceuticals Ltd. (VM:CA) (OTC Pink:VYYRF) ("Voyageur" or the "Company") a radiology contrast media company focused on vertical ...
CALGARY, ALBERTA - August 21, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company"), a radiology contrast media company focused on vertical ...
What is Double-contrast Barium Enema? Double-contrast barium enema is a radiological technique that can be used to screen individuals for colorectal cancer. It is preferred in individuals who cannot ...
Calgary, Alberta, Canada – TheNewswire - January 13, 2025 - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Q: Which doctor should I visit to get a double-contrast barium enema done? A: You should visit your health care provider if you are interested in getting a Double-contrast barium enema done. He will ...
Is single-contrast barium enema acceptable management for the patient following unsuccessful colonoscopy? Is air contrast better, or should a repeat colonoscopy be planned? The question posed is ...
CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...
To the Editor: The Clinical Practice article by Inadomi (Jan. 12 issue) 1 did not mention the potential role of double-contrast barium enema. Double-contrast barium enema, sometimes referred to as air ...
Voyageur announced on January 13, 2025 (Testing) that the company commenced testing of its current barium contrast media formulations in human subjects, to ensure efficacy and safety in clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results